{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:48:28Z","timestamp":1792673308007,"version":"4.5.0"},"reference-count":32,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"10","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2026,10,22]]},"DOI":"10.1167\/tvst.15.10.31","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:30:51Z","timestamp":1792672251000},"page":"31","source":"Crossref","is-referenced-by-count":0,"title":["Monocyte Chemoattractant Protein-1 Level Measured in Dried Blood Spots as a Biomarker for Diabetic Retinopathy"],"prefix":"10.1167","volume":"15","author":[{"given":"Xinyi","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA"},{"name":"Department of Ophthalmology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"El-Sabrout","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA"},{"name":"Department of Ophthalmology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Le","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA"},{"name":"Department of Ophthalmology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Tran","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA"},{"name":"Department of Ophthalmology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Huh","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA"},{"name":"Department of Ophthalmology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelynn E.","family":"Mackenzie","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA"},{"name":"Department of Ophthalmology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Y.","family":"Xin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA"},{"name":"Department of Ophthalmology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA"},{"name":"Department of Ophthalmology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA"},{"name":"Department of Ophthalmology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA"},{"name":"Department of Ophthalmology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Lamy","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay M.","family":"Stewart","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA"},{"name":"Department of Ophthalmology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"8","key":"bib1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1001\/jamaophthalmol.2023.2289","article-title":"Prevalence of diabetic retinopathy in the US in 2021","volume":"141","author":"Lundeen","year":"2023","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"bib2","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1167\/iovs.04-1057","article-title":"Plasma inflammatory markers in diabetic retinopathy","volume":"46","author":"Meleth","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"bib3","doi-asserted-by":"publisher","first-page":"e000717","DOI":"10.1136\/bmjophth-2021-000717","article-title":"Pro-inflammatory cytokine profile is present in the plasma of Mexican patients with different stages of diabetic retinopathy secondary to type 2 diabetes","volume":"6","author":"Quevedo-Mart\u00ednez","year":"2021","journal-title":"BMJ Open Ophthalmol"},{"issue":"4","key":"bib4","doi-asserted-by":"publisher","first-page":"968","DOI":"10.2337\/dc10-1675","article-title":"Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the Joslin 50-year medalist study","volume":"34","author":"Sun","year":"2011","journal-title":"Diabetes Care"},{"issue":"3","key":"bib5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJMoa020233","article-title":"Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure","volume":"347","author":"Maisel","year":"2002","journal-title":"N Engl J Med"},{"issue":"8","key":"bib6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1167\/tvst.14.8.22","article-title":"Sex differences in inflammatory plasma proteins in patients with diabetic retinopathy","volume":"14","author":"Chen","year":"2025","journal-title":"Transl Vis Sci Technol"},{"issue":"6","key":"bib7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S2213-8587(18)30050-0","article-title":"Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study","volume":"6","author":"Herrington","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"bib8","doi-asserted-by":"publisher","first-page":"e2317","DOI":"10.1210\/clinem\/dgae092","article-title":"Diabetes duration, cholesterol levels, and risk of cardiovascular diseases in individuals with type 2 diabetes","volume":"109","author":"Kim","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"bib9","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.12669\/pjms.345.15224","article-title":"Incidence of microvascular complications of type 2 diabetes: a 12 year longitudinal study from Karachi-Pakistan","volume":"34","author":"Fawwad","year":"2018","journal-title":"Pak J Med Sci"},{"issue":"7","key":"bib10","first-page":"e87619","article-title":"The impact of the duration of type 2 diabetes mellitus on biochemical and oxidative stress parameters and renal function","volume":"17","author":"Zukic","year":"2025","journal-title":"Cureus"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"904347","DOI":"10.3389\/fendo.2022.904347","article-title":"The clinical characteristics of Chinese elderly patients with different durations of type 2 diabetes mellitus","volume":"13","author":"Yu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"bib12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/biomet\/93.3.491","article-title":"Adaptive linear step-up procedures that control the false discovery rate","volume":"93","author":"Benjamini","year":"2006","journal-title":"Biometrika"},{"issue":"3","key":"bib13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1167\/tvst.10.3.12","article-title":"Sex-based analysis of potential inflammation-related protein biomarkers in the aqueous humor of patients with diabetes mellitus","volume":"10","author":"Haq","year":"2021","journal-title":"Transl Vis Sci Technol"},{"issue":"6","key":"bib14","doi-asserted-by":"publisher","first-page":"100580","DOI":"10.1016\/j.xops.2024.100580","article-title":"Sex differences in inflammation-related biomarkers detected with OCT in patients with diabetic macular edema","volume":"4","author":"Chen","year":"2024","journal-title":"Ophthalmol Sci"},{"issue":"8","key":"bib15","first-page":"1495","article-title":"Performance properties of filter paper devices for whole blood collection","volume":"47","author":"Mei","year":"2001","journal-title":"Clin Chem"},{"issue":"4","key":"bib16","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1021\/ac8022839","article-title":"Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method","volume":"81","author":"Spooner","year":"2009","journal-title":"Anal Chem"},{"issue":"4","key":"bib18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s12079-018-00500-8","article-title":"Monocyte chemoattractant protein-1 (MCP-1\/CCL2) in diabetic retinopathy: latest evidence and clinical considerations","volume":"13","author":"Taghavi","year":"2019","journal-title":"J Cell Commun Signal"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.exer.2013.01.008","article-title":"Autocrine CCL2, CXCL4, CXCL9 and CXCL10 signal in retinal endothelial cells and are enhanced in diabetic retinopathy","volume":"109","author":"Nawaz","year":"2013","journal-title":"Exp Eye Res"},{"issue":"10","key":"bib20","doi-asserted-by":"publisher","first-page":"e108508","DOI":"10.1371\/journal.pone.0108508","article-title":"Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy","volume":"9","author":"Rangasamy","year":"2014","journal-title":"PLoS ONE"},{"issue":"4","key":"bib21","first-page":"741","article-title":"CCR2-positive monocytes contribute to the pathogenesis of early diabetic retinopathy in mice","volume":"66","author":"Saadane","year":"2023","journal-title":"Diabetologia"},{"issue":"10","key":"bib22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/tvst.9.10.3","article-title":"Comparative analysis of multiplex platforms for detecting vitreous biomarkers in diabetic retinopathy","volume":"9","author":"Lamy","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"bib23","doi-asserted-by":"crossref","first-page":"6928524","DOI":"10.1155\/2019\/6928524","article-title":"Aqueous humor mediator and cytokine aberrations in diabetic retinopathy and diabetic macular edema: a systematic review and meta-analysis","volume":"2019","author":"Wu","year":"2019","journal-title":"Dis Markers"},{"issue":"5","key":"bib24","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.jdiacomp.2017.02.017","article-title":"Association of increased levels of MCP-1 and cathepsin-D in young onset type 2 diabetes patients (T2DM-Y) with severity of diabetic retinopathy","volume":"31","author":"Reddy","year":"2017","journal-title":"J Diabetes Complications"},{"issue":"12","key":"bib25","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1007\/s00417-014-2651-1","article-title":"Association of monocyte chemoattractant protein-1 (MCP-1)2518A\/G polymorphism with proliferative diabetic retinopathy in northern Chinese type 2 diabetes","volume":"252","author":"Dong","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.mce.2016.09.009","article-title":"CCR5-?32 gene polymorphism is associated with retinopathy in patients with type 1 diabetes","volume":"439","author":"Slominski","year":"2017","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"bib27","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3349\/ymj.2013.54.3.621","article-title":"Association of monocyte chemoattractant protein-1 (MCP-1) 2518A\/G polymorphism with proliferative diabetic retinopathy in Korean type 2 diabetes","volume":"54","author":"Jeon","year":"2013","journal-title":"Yonsei Med J"},{"issue":"4","key":"bib28","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.ajo.2011.03.033","article-title":"Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema","volume":"152","author":"Sohn","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"bib29","first-page":"2537","article-title":"Vitreous cytokine levels following the administration of a single 0.19 mg fluocinolone acetonide (ILUVIEN\u00ae) implant in patients with refractory diabetic macular edema (DME)\u2014results from the ILUVIT study","volume":"260","author":"Deuchler","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"7633","DOI":"10.1038\/s41598-017-07230-8","article-title":"Analysis of inflammatory cytokine and TLR expression levels in type 2 diabetes with complications","volume":"7","author":"Gupta","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"bib31","doi-asserted-by":"publisher","first-page":"F697","DOI":"10.1152\/ajprenal.00016.2008","article-title":"MCP-1\/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy","volume":"294","author":"Tesch","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"issue":"19","key":"bib32","doi-asserted-by":"publisher","first-page":"10785","DOI":"10.3390\/ijms251910785","article-title":"Unveiling the role of Schwann cell plasticity in the pathogenesis of diabetic peripheral neuropathy","volume":"25","author":"Abd Razak","year":"2024","journal-title":"Int J Mol Sci"},{"key":"bib17","volume-title":"The ELISA Guidebook","author":"Crowther","year":"2001"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/tvst.arvojournals.org\/article.aspx?doi=10.1167\/tvst.15.10.31","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:30:53Z","timestamp":1792672253000},"score":1,"resource":{"primary":{"URL":"http:\/\/tvst.arvojournals.org\/article.aspx?doi=10.1167\/tvst.15.10.31"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,5]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.15.10.31","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,22]]}}}